According to a study, immunotherapy significantly improves lymphomatoid granulomatosis patients' chances of survival.

Published Date: 05 Apr 2023

Those with low-grade lymphomatoid granulomatosis who receive treatment with the immunotherapy drug interferon alfa-2b appear to benefit from it, according to the findings of a clinical trial conducted by National Institutes of Health (NIH) researchers.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

2.

Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib

3.

In prostate cancer survivorship, sleep disturbances are underappreciated.

4.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

5.

a cutting-edge cancer diagnostic tool.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot